EP3419650

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    24.2.2017
  • EP published:
    2.6.2021
  • EP application number:
    17757375.5
  • Max expiry date:
    23.2.2037
  • Title:
    LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

Timeline

Today
24.2.2017EP application
2.6.2021EP Publication

Owner

  • Name:
    Alexion Pharmaceuticals, Inc.
  • Address:
    121 Seaport Boulevard, Boston, MA 02210, US

Inventor

  • Name:
    NGUYEN, Phuong M.
  • Address:
    South San Francisco California 94080, US

Priority

  • Number:
    201662299369 P
  • Date:
    24.2.2016
  • Country:
    US

Classification

  • Categories:
    A61K 38/36, A61K 38/48, A61K 9/19, C07K 14/00, A61K 9/00, A61P 9/00, A61P 39/02, A61P 7/00, A61K 47/18, A61K 47/26, C12N 9/64

Upload documents